Viewing Study NCT02283658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-02-23 @ 3:02 PM
Study NCT ID: NCT02283658
Status: COMPLETED
Last Update Posted: 2020-10-23
First Post: 2014-11-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Sponsor: Mayo Clinic
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Endometrioid Adenocarcinoma View
None Ovarian Seromucinous Carcinoma View
None Ovarian Serous Cystadenocarcinoma View
None Ovarian Serous Surface Papillary Adenocarcinoma View
None Recurrent Fallopian Tube Carcinoma View
None Recurrent Ovarian Carcinoma View
None Recurrent Ovarian Germ Cell Tumor View
None Recurrent Primary Peritoneal Carcinoma View
None Undifferentiated Ovarian Carcinoma View
Keywords: